- Benzinga•21 hours ago
Barclays believes investors are underestimating St. Jude Medical, Inc. (NYSE: STJ )’s pipeline and growth potential in future periods as it is working to close its merger with Abbott Laboratories (NYSE: ...
- PR Newswire•23 hours ago
WALTHAM, Mass., Oct. 20, 2016 /PRNewswire/ -- Alere Inc. (ALR), a global leader in rapid diagnostics announced that it has received notification from the Ministry of Commerce of the People's Republic of China (PRC) that after completing its review of the proposed acquisition the PRC has decided not to prohibit the acquisition of Alere Inc. by Abbott Laboratories (ABT). As previously announced on February 1, 2016, Alere has entered into a definitive agreement under which Abbott will acquire Alere for $56 per common share in cash.
Abbott Laboratories (ABT)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||40.40 x 1200|
|Ask||40.41 x 1300|
|Day's Range||40.30 - 40.56|
|52wk Range||36.00 - 46.38|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||26.64|
|Avg Vol (3m)||9,383,583|
|Dividend & Yield||1.04 (2.56%)|